| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase 3 randomized trial of the safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults ≥ 60 years of age in Japan, South Korea, and Taiwan
|
Haranaka, Miwa
|
|
|
42 |
5 |
p. 1071-1077
|
artikel
|
| 2 |
A rabies mRNA vaccine with H270P mutation in its glycoprotein induces strong cellular and humoral immunity
|
Cao, Han
|
|
|
42 |
5 |
p. 1116-1121
|
artikel
|
| 3 |
Are COVID-19 vaccination mandates for healthcare workers effective? A systematic review of the impact of mandates on increasing vaccination, alleviating staff shortages and decreasing staff illness
|
Okpani, Arnold I.
|
|
|
42 |
5 |
p. 1022-1033
|
artikel
|
| 4 |
Background incidence rates of health outcomes in populations at risk for Lyme disease using US administrative claims data
|
Dreyfus, Jill
|
|
|
42 |
5 |
p. 1094-1107
|
artikel
|
| 5 |
Boot Camp Translation using Community-Engaged messaging for adolescent Vaccination: A Cluster-Randomized trial
|
Cataldi, Jessica R.
|
|
|
42 |
5 |
p. 1078-1086
|
artikel
|
| 6 |
Determinants of SARS-CoV-2 IgG response and decay in Canadian healthcare workers: A prospective cohort study
|
Cherry, Nicola
|
|
|
42 |
5 |
p. 1168-1178
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
42 |
5 |
p. ii
|
artikel
|
| 8 |
Erratum to “Examining vaccine hesitancy among a diverse sample of Canadian adults” [Vaccine 42(2) (2024) 129–135]
|
Burns, Kathleen E.
|
|
|
42 |
5 |
p. 1193
|
artikel
|
| 9 |
Examining changes in sense of purpose before, during, and after COVID-19 vaccination
|
Hill, Patrick L.
|
|
|
42 |
5 |
p. 1087-1093
|
artikel
|
| 10 |
Flu-COVID combo recombinant protein vaccines elicited protective immune responses against both influenza and SARS-CoV-2 viruses infection
|
Huang, Ying
|
|
|
42 |
5 |
p. 1184-1192
|
artikel
|
| 11 |
How manufacturing won or lost the COVID-19 vaccine race
|
King, Michael L.
|
|
|
42 |
5 |
p. 1004-1012
|
artikel
|
| 12 |
Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort study
|
Hamad Saied, Mohamad
|
|
|
42 |
5 |
p. 1145-1153
|
artikel
|
| 13 |
Impact of innovative immunization strategy on PCV13 vaccination coverage among children under 5 years in Weifang city, China: A retrospective study
|
Wang, Chun-Ping
|
|
|
42 |
5 |
p. 1136-1144
|
artikel
|
| 14 |
Impact of the 'Health on Wheels' (HoW) strategy on COVID-19 vaccination coverage in hard-to-reach communities in Alta Verapaz, Guatemala, 2022
|
Balsells, Evelyn
|
|
|
42 |
5 |
p. 1179-1183
|
artikel
|
| 15 |
Implications of vaccine non-specific effects on licensure of new vaccines
|
Munkwase, Grant
|
|
|
42 |
5 |
p. 1013-1021
|
artikel
|
| 16 |
Influence of Community Determinants on Barriers and Facilitators to COVID-19 Vaccine Uptake: Regional Stakeholders’ Perspectives
|
Russ, Savanah
|
|
|
42 |
5 |
p. 1160-1167
|
artikel
|
| 17 |
Safety, immunogenicity and efficacy of Relcovax®, a dual receptor binding domain (RBD) and nucleocapsid (N) subunit protein vaccine candidate against SARS-CoV-2 virus
|
Sathe, Nikhil
|
|
|
42 |
5 |
p. 1051-1064
|
artikel
|
| 18 |
Short term safety of BNT162b2 (Pfizer–BioNTech) SARS-CoV-2 vaccine among children aged 5–11 years, a nationwide parental survey
|
Shapiro Ben David, Shirley
|
|
|
42 |
5 |
p. 1154-1159
|
artikel
|
| 19 |
Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates
|
Pal, Ranajit
|
|
|
42 |
5 |
p. 1122-1135
|
artikel
|
| 20 |
Systematic review of cost projections of new vaccine introduction
|
Levin, Ann
|
|
|
42 |
5 |
p. 1042-1050
|
artikel
|
| 21 |
Test negative design for vaccine effectiveness estimation in the context of the COVID-19 pandemic: A systematic methodology review
|
Mésidor, Miceline
|
|
|
42 |
5 |
p. 995-1003
|
artikel
|
| 22 |
The association between influenza vaccination, cardiovascular mortality and hospitalization: A living systematic review and prospective meta-analysis
|
Liu, Rong
|
|
|
42 |
5 |
p. 1034-1041
|
artikel
|
| 23 |
What is the relevancy of a surveillance of mumps without a systematic laboratory confirmation in highly immunized populations? Epidemiology of suspected and biologically confirmed mumps cases seen in general practice in France between 2014 and 2020
|
Prévot-Monsacré, Pol
|
|
|
42 |
5 |
p. 1065-1070
|
artikel
|
| 24 |
What would have happened anyway? Population data source considerations when estimating background incident rates of adverse events following immunisation to inform vaccine safety
|
Clothier, Hazel J.
|
|
|
42 |
5 |
p. 1108-1115
|
artikel
|
Tijdschrift beschrijving